PCN86 Cost-Effectiveness of Rituximab in Follicular Lymphoma First Line Maintenance Treatment from Public Payer Perspective in Poland
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1187
https://www.valueinhealthjournal.com/article/S1098-3015(11)02749-5/fulltext
Title :
PCN86 Cost-Effectiveness of Rituximab in Follicular Lymphoma First Line Maintenance Treatment from Public Payer Perspective in Poland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02749-5&doi=10.1016/j.jval.2011.08.1187
First page :
A449
Section Title :
Cancer
Open access? :
No
Section Order :
1144